ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 20:32:51 GMT 2025` Edited by `admin` on `Tue Apr 01 20:32:51 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	JMN849I3XV
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

2'-PHOSPHO-ADP-RIBOSYL CYCLASE

Preferred Name

English

ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1

Common Name

English

ADPRC 1

Common Name

English

CADPR HYDROLASE 1

Common Name

English

ADP-RIBOSYL CYCLASE 1

Common Name

English

2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE

Common Name

English

CD38

Common Name

English

T10

Common Name

English

2'-PHOSPHO-ADP-RIBOSYL CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE

Common Name

English

CYCLIC ADP-RIBOSE HYDROLASE 1

Common Name

English

Code System Code Type Description

UNIPROT

P28907

Created by admin on Tue Apr 01 20:32:51 GMT 2025 , Edited by admin on Tue Apr 01 20:32:51 GMT 2025

PRIMARY

FDA UNII

JMN849I3XV

Created by admin on Tue Apr 01 20:32:51 GMT 2025 , Edited by admin on Tue Apr 01 20:32:51 GMT 2025

PRIMARY

From	To
1_67	1_82
1_99	1_180
1_160	1_173
1_254	1_275
1_287	1_296

Glycosylation Link Type	Site
N	1_100
N	1_164
N	1_209
N	1_219

Related Record Type Details


					3O9FA4XC02

FELZARTAMAB

INHIBITOR -> TARGET

Comments:

ADCC and ADCP are considered to be primary modes of action for MOR202 targeting CD38 high expressing cells.

Qualification:

EC50

Amount:


					TN8CEX4UT2

MODAKAFUSP ALFA

LIGAND->TARGET

Amount:


					7H3Q0M9END

GBR-1342

LIGAND->TARGET


					BF2SMF4KKT

DARATUMUMAB-DFO ZR-89

RADIOLIGAND->TARGET

Amount:


					0XMR8L9LOL

MEZAGITAMAB

INHIBITOR -> TARGET

Comments:

depletes human tumor cells expressing CD38 by antibody-dependent cellular cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC).

Amount:


					R30772KCU0

ISATUXIMAB

LIGAND->TARGET


					4Z63YK6E0E

DARATUMUMAB

INHIBITOR -> TARGET

Amount:


					2KG6QX4W0V

NICOTINAMIDE MONONUCLEOTIDE

SUBSTRATE -> METABOLIC ENZYME

Amount:


					GT2R696LEM

Lumrotatug

LIGAND->TARGET

Amount:


					8TE669PH9F

2-(1H-Imidazol-1-yl)-N-[2-(2-methoxyethoxy)-5-pyrimidinyl]-6-(trifluoromethyl)-4-pyrimidinecarboxamide

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL